不让做的事
发表于 2025-3-21 17:29:20
书目名称Atlas of Cutaneous Lymphomas影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0164149<br><br> <br><br>书目名称Atlas of Cutaneous Lymphomas读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0164149<br><br> <br><br>
Interstellar
发表于 2025-3-21 20:44:46
http://reply.papertrans.cn/17/1642/164149/164149_2.png
HEAVY
发表于 2025-3-22 00:53:02
https://doi.org/10.1007/978-3-030-25237-3s condition is considered a provisional entity in the fourth edition of the WHO/EORTC guidelines . This chapter will discuss the clinical presentation, prognosis, treatment, histopathology, immunophenotype, and differential diagnosis of pcGDTCL. It closes with two clinical cases, including clinical images and histopathology.
开始从未
发表于 2025-3-22 08:31:50
Introduction to the T-Cell Lymphomas, 2]. The WHO/EORTC classification recognizes 15 cutaneous lymphomas, 10 of which are T-cell lymphomas. Their incidence and various organizational schemas for understanding CTCL are offered in this chapter. Each of the lymphomas is addressed individually in subsequent chapters.
LUDE
发表于 2025-3-22 09:58:46
Primary Cutaneous Gamma-Delta T-Cell Lymphoma,s condition is considered a provisional entity in the fourth edition of the WHO/EORTC guidelines . This chapter will discuss the clinical presentation, prognosis, treatment, histopathology, immunophenotype, and differential diagnosis of pcGDTCL. It closes with two clinical cases, including clinical images and histopathology.
愤愤不平
发表于 2025-3-22 13:58:29
Michael J. Urick,Vaughn Crandall, poikilodermatous MF, and hypopigmented MF. This chapter will discuss the clinical presentation, prognosis, treatment, histopathology, immunohistochemistry, and molecular biology of several of the subtypes of MF. It closes with five clinical cases, each representing a different subtype of MF.
土产
发表于 2025-3-22 18:29:42
http://reply.papertrans.cn/17/1642/164149/164149_7.png
金丝雀
发表于 2025-3-22 23:36:35
http://reply.papertrans.cn/17/1642/164149/164149_8.png
gain631
发表于 2025-3-23 05:06:09
http://reply.papertrans.cn/17/1642/164149/164149_9.png
menopause
发表于 2025-3-23 06:16:45
http://reply.papertrans.cn/17/1642/164149/164149_10.png